BUY Tatva Chintan Pharma Chem Limited — Aastha Jain, Hem Securities
byAastha Jain, Hem SecuritiesHorizon: NA (inferred Swing (≤2wk))21 Oct 2026via Zee Business (Live)
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Tatva Chintan Q2 Review: ICICI Securities Hikes Target Price After Strong Numbers; Check Potential Upside
NewsNdtv-Profit·21 Oct · today
Tatva Chintan shares hit another 52-week high after reporting highest-ever quarterly turnover
NewsCnbc-Tv18·21 Oct · today
1 other SEBI-registered advisor has an active swing BUY call on this stock, issued in the last 14 days
Advisor consensus · same horizon·21 Oct · today
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Tatva Chintan Pharma Chem
- BUY — Ansh Jogendra Bhilwar21 Oct 2026 · ~2 weeks · target ₹2,000 · Expired
- BUY — ICICI Securities20 Oct 2026 · ~1 year · target ₹2,385 · Active
- BUY — Kush Bohra24 Sept 2026 · ~2 weeks · target ₹1,915 · SL hit
- BUY — Vaishali Parekh, Prabhudas Lilladher27 Aug 2026 · ~2 weeks · target ₹1,850 · Expired
- BUY — Laxmikant Shukla, YES Securities20 Jul 2026 · ~2 weeks · target ₹1,820 · Target hit
More from Aastha Jain, Hem Securities
- BUY Indian Bank21 Oct 2026 · Same day · target ₹880 · Expired
- BUY Tech Mahindra21 Oct 2026 · Next day · target ₹1,850 · Active
- BUY Himachal Futuristic Communications21 Oct 2026 · ~3 months · target ₹295 · Active
- BUY L&T Technology Services21 Oct 2026 · Same day · target ₹3,700 · Expired
- BUY Zensar Technologies19 Oct 2026 · ~2 weeks · target ₹550 · Active

